Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: a prospective cohort study

Autor: Thanachai Panaput, Somnuek Domrongkitchaiporn, Cholatip Pongskul, Dhavee Sirivongs, Surapong Narenpitak, Kannika Niwattayakul, Ammrit Suwattanasin, Sajja Tatiyanupanwong, Pisith Intarawongchot, Thathsalang Keobounma, Sirirat Anutrakulchai, Bandit Thinkhamrop, Pakorn Tungkasereerak, Chavasak Kanokkantapong, Laksamon Praderm, Jirasak Anukulanantachai
Rok vydání: 2014
Předmět:
Zdroj: Blood purification. 38(3-4)
ISSN: 1421-9735
Popis: Background/Aims: We aimed to define the dosing and risk factors for death in patients undergoing twice-weekly hemodialysis. Methods: A prospective multi-center cohort study was conducted with one-year observation. Patients treated with twice- or thrice-weekly hemodialysis were identified. Death and first admission were the outcomes. spKt/V was a factor of interest. Results: We enrolled 504 twice-weekly and 169 thrice-weekly hemodialysis patients. The mean weekly values of spKt/V in the two groups were 3.4 and 5.1. The one-year survival rate and times to hospitalization were similar in both groups. The hazard ratios for death in higher spKt/V quartile was not associated with lower mortality, p = 0.70. The four significant predictors for death were serum albumin, HR = 2.6, current smoking, HR = 19.3, age, HR = 1.1, and the Index of Coexistent Disease [ICED], HR = 1.9. Conclusion: The effect of spKt/V on short-term mortality was not obvious in twice-weekly dialysis patients. Attention should be paid to patients who smoke, have hypoalbuminemia, are elderly, or have a high ICED.
Databáze: OpenAIRE